| Filed On | Filing |
|---|---|
| 29 Sep 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Sold 76 shares ($14K) |
| 03 Sep 2026 |
Form 4: Roque Vitor, EVP & Chief Financial Officer
Gave up 190 shares to cover exercise price or tax |
| 27 Aug 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Sold 165 shares ($31.1K) |
| 24 Aug 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Gave up 1,049 shares to cover exercise price or tax |
| 14 Aug 2026 |
Form 4: Polen Thomas E Jr, Director
Received 43,278 shares by exercise or conversion ($7.24M) · Returned 39,126 shares to the issuer ($7.24M) · Sold 4,152 shares ($768K) |
| 12 Aug 2026 |
Form 4: Goette Roland, EVP and President, EMEA
Sold 2,438 shares ($441K) |
| 06 Aug 2026 |
Form 4: Huffines Robert Luther, Director
Granted 189 Rights to Common Stock Under BD Deferred Compensation Plan ($31.3K) |
| 06 Aug 2026 |
Form 4: Byington Carrie L, Director
Granted 94 Rights to Common Stock Under BD Deferred Compensation Plan ($15.6K) |
| 28 Jul 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Sold 75 shares ($11.8K) |
| 06 Jul 2026 |
Form 4: Muhsin Bilal, EVP & President Connected Care
Received 14,342 shares as a grant or award · Gave up 1,935 shares to cover exercise price or tax |
| 26 Jun 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Sold 75 shares ($11.5K) |
| 25 Jun 2026 |
Form 4: Garrison Michael David, EVP & Pres Med.Essntl&BioPharm
Sold 1,100 shares ($160K) |
| 11 Jun 2026 |
Form 4: Garrison Michael David, EVP & Pres Med.Essntl&BioPharm
Sold 1,100 shares ($167K) |
| 03 Jun 2026 |
Form 4: Polen Thomas E Jr, Director
Received 20,209 shares by exercise or conversion ($2.55M) · Returned 17,445 shares to the issuer ($2.55M) · Sold 2,764 shares ($405K) |
| 02 Jun 2026 |
Form 4: Menziuso Peter, EVP and President, BDI
Received 14,258 shares as a grant or award |
| 27 May 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Sold 75 shares ($11.1K) |
| 08 May 2026 |
Form 4: Huffines Robert Luther, Director
Granted 210 Rights to Common Stock Under BD Deferred Compensation Plan ($31.3K) |
| 08 May 2026 |
Form 4: Byington Carrie L, Director
Granted 105 Rights to Common Stock Under BD Deferred Compensation Plan ($15.6K) |
| 08 May 2026 |
Form 4: Roque Vitor, EVP & Chief Financial Officer
Received 1,721 shares as a grant or award |
| 28 Apr 2026 |
Form 4: Feld Michael, EVP, Chief Revenue Officer
Sold 74 shares ($11.2K) |
Loading...